LIFECORE BIOMEDICAL, INC. \DE\ — Director's Dealing 2016

Jun 1, 2016

SEC Form 4/A — Form 4/A

Issuer: LANDEC CORP \CA\ (LNDC)
CIK: 0001005286
Period of Report: 2016-05-26

Reporting Person: HIEBERT LARRY D (Executive Vice President)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2016-05-25	Incentive Stock Option (Right to Buy)	$11.36	M	15000	Acquired	2023-05-25	Common Stock (15000)	Direct
2016-05-25	Right to Buy Restricted Stock Unit (RSU)	$	M	5000	Acquired		Common Stock (5000)	Direct

Footnotes

F1: Restricted Stock Units will vest on the 3rd anniversary of the grant date and will be automatically settled in shares of common stock.

F2: The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis.

F3: The proper transaction date for this grant is May 25, 2016 versus May 26, 2016. Therefore, the price is $11.36 versus $11.49.